[Renren Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price To address this issue, Renren is considering a change to the number of Class A ordinary shares represented by each ADS. If the ADS ratio is changed, the ADS price is expected to increase proportionally, although Renre]
[Renren Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price To address this issue, Renren is considering a change to the number of Class A ordinary shares represented by each ADS. If the ADS ratio is changed, the ADS price is expected to increase proportionally, although Renre]
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 AMC Entertainment Holdings, Inc. Announces Quarterly Dividend of $0.20 Per Share LEAWOOD, KANSAS - (August 5, 2019) About AMC Entertainment Holdings, Inc. Website Information This press release, along with]
[INVESTOR RELATIONS: John Merriwether, 866-248-3872 MEDIA CONTACTS: Ryan Noonan, (913) 213-2183 AMC Entertainment Holdings, Inc. Announces Quarterly Dividend of $0.20 Per Share LEAWOOD, KANSAS - (August 5, 2019) About AMC Entertainment Holdings, Inc. Website Information This press release, along with]
[1 Announcement dated August 2, 2019 in respect of notification of board meeting. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profitability; changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunicati]
[1 Announcement dated August 2, 2019 in respect of notification of board meeting. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profitability; changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunicati]
[FOR RELEASE August 5, 2019 China Biologic Reports Financial Results for the Second Quarter of 2019 —2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms — —1H19 Total Sales Up 14.0% YoY]
[FOR RELEASE August 5, 2019 China Biologic Reports Financial Results for the Second Quarter of 2019 —2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms — —1H19 Total Sales Up 14.0% YoY]
